Approval · Notice of Compliance 19119 · 2017
CLASTEON: Notice of Compliance 19119
Issued March 29, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19119
- Date
- March 29, 2017
- Company
- Sunovion Pharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the product monograph in response to an advisement letter regarding osteonecrosis of the jaw (onj)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLASTEON | Not yet assigned | — |
Medicinal ingredients
- CLODRONATE DISODIUM 400 MG per MG